Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma
Sancy Ann Leachman, G. Long, Zhi Jin Xu, A. Eggermont et al.
Journal
JAMA Network Open
Topics
Cutaneous Melanoma Detection and Management
article
Adjuvant Pembrolizumab for Stage IIB or IIC Melanoma
Sancy Ann Leachman, G. Long, Zhi Jin Xu, A. Eggermont, Jason Luke, Muhammad A. Khattak, Clemens Krepler, Dirk Schadendorf, Paolo A. Ascierto, Piotr Rutkowski, Mizuho Fukunaga-Kalabis
article en
Abstract
No abstract available for this paper.
Publication Tag
JAMA Network OpenVol. 9(2)
Institutions
Edith Cowan University (AU), Merck & Co., Inc., Rahway, NJ, USA (United States) (US), The University of Sydney (AU), Oregon Health & Science University (US), Royal North Shore Hospital (AU), Fiona Stanley Hospital (AU), University Medical Center Utrecht (NL), Ruhrlandklinik (DE), Melanoma Institute Australia (AU), Essen University Hospital (DE), Princess Máxima Center (NL), UPMC Hillman Cancer Center (US), University of Pittsburgh Medical Center (US), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Deutsches Konsortium für Translationale Krebsforschung (DE), University of Duisburg-Essen (DE), University of Naples Federico II (IT), Ludwig-Maximilians-Universität München (DE)